DATA#3 LIMITED. (DTL)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

DTL - DATA#3 LIMITED.

FNArena Sector : IT & Support
Year End: June
GICS Industry Group : Software & Services
Debt/EBITDA: 0.34
Index: ASX200 | ASX300 | ALL-ORDS | ALL-TECH

Data#3 is an Australian information and communications technology company. It provides IT solutions to businesses and government markets. It has been listed on the ASX since 1997.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$7.41

13 Dec
2024

-0.050

OPEN

$7.45

-0.67%

HIGH

$7.47

506,313

LOW

$7.33

TARGET
$8.883 19.9% upside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
APX . FLN . HSN . IRI . OCL . STG . TNE .
FNARENA'S MARKET CONSENSUS FORECASTS
DTL: 1
Title FY23
Actual
FY24
Actual
FY25
Forecast
FY26
Forecast
EPS (cps) xxx 28.0 30.7 xxx
DPS (cps) xxx 25.5 26.9 xxx
EPS Growth xxx 16.9% 9.5% xxx
DPS Growth xxx 16.4% 5.5% xxx
PE Ratio xxx N/A 24.2 xxx
Dividend Yield xxx N/A 3.6% xxx
Div Pay Ratio(%) xxx 91.1% 87.7% xxx

Dividend yield today if purchased 3 years ago: 4.39%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

3.44

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 13/09 - ex-div 12.90c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 201920202021202220232024
EPS Basic xxxxxxxxxxxxxxx28.0
DPS All xxxxxxxxxxxxxxx25.5
Sales/Revenue xxxxxxxxxxxxxxx805.7 M
Book Value Per Share xxxxxxxxxxxxxxx48.4
Net Operating Cash Flow xxxxxxxxxxxxxxx-86.2 M
Net Profit Margin xxxxxxxxxxxxxxx5.38 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201920202021202220232024
Return on Capital Employed xxxxxxxxxxxxxxx60.46 %
Return on Invested Capital xxxxxxxxxxxxxxx48.08 %
Return on Assets xxxxxxxxxxxxxxx4.77 %
Return on Equity xxxxxxxxxxxxxxx60.46 %
Return on Total Capital xxxxxxxxxxxxxxx56.99 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx-124.7 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201920202021202220232024
Short-Term Debt xxxxxxxxxxxxxxx4 M
Long Term Debt xxxxxxxxxxxxxxx17 M
Total Debt xxxxxxxxxxxxxxx21 M
Goodwill - Gross xxxxxxxxxxxxxxx12 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx276 M
Price To Book Value xxxxxxxxxxxxxxx17.28

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201920202021202220232024
Capex xxxxxxxxxxxxxxx0.6 M
Capex % of Sales xxxxxxxxxxxxxxx0.08 %
Cost of Goods Sold xxxxxxxxxxxxxxx542 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx210 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx0 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.3

No. Of Recommendations

3
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgan Stanley

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

21/10/2024

3

Upgrade to Neutral from Sell

$8.00

7.96%

UBS upgrades Data#3 to Neutral from Sell on the back of a fall of -18% in the stock price since August results with much of the election risk now discounted in the share price.

The analyst reiterates belief in the company as being well run with exposure to structural IT spend which should support an 11% compound average growth rate in EPS from FY25 to FY28.

Some weakness is flagged as possible for FY25 with a risk of budget cuts from the Qld government and risks to Federal Government spending in in late 2025, post election.

Target price falls -8% to $8. Neutral rated.

FORECAST
UBS forecasts a full year FY25 EPS of 31.00 cents.
UBS forecasts a full year FY26 EPS of 34.00 cents.

Morgans

xx/xx/xxxx

3

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

3

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Jarden

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Goldman Sachs

01/11/2024

3

Neutral

$8.25

11.34%

Goldman Sachs observes Data#3's AGM update highlighted a robust FY25 sales pipeline, with  10% year-on-year pre-tax profit increase expected for 1H25. The growth is underpinned  by strong public infrastructure and health verticals.

The company is also experiencing growth in recurring software and services revenue, but earnings remain second-half weighted, with potential upside if performance improves.

Goldman Sachs raises FY25-26 pre-tax profit forecasts by 4% and 3%,respectively, as Data#3 shifts towards recurring revenue streams in software and services

Neutral rating unchanged. Target price lifts 1% to $8.25.

FORECAST
Goldman Sachs forecasts a full year FY25 dividend of 29.00 cents and EPS of 32.00 cents.
Goldman Sachs forecasts a full year FY26 dividend of 31.00 cents and EPS of 34.00 cents.

Wilsons

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

DTL STOCK CHART